|
A Binghamton University researcher will receive $1.33 million from the National Institutes of Health to support Parkinson’s disease research.
Christopher Bishop, assistant professor of psychology, said his primary interest lies not only in the treatment of Parkinson’s but also in the side effects of that treatment. His work has important implications for the roughly 1 million Americans who have Parkinson’s.
The five-year grant from the National Institute for Neurological Disorders and Stroke will allow Bishop and his team to study serotonin compounds that reduce glutamate following L-DOPA treatment.
“I was drawn to this field,” Bishop said, “because not only am I asking, ‘How does it work?’ but also ‘How does it help with treatment?’ I think that has been a motivation for me.”
|